Tomás Regueira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomás Regueira has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Andres Ferre
Critical Care Department, Finis Terrae University Faculty of Medicine, Santiago, Chile
2 shared publications Jorge Dreyse
Centro de Pacientes Críticos, Clínica Las Condes, Santiago, Chile
2 shared publications- Andrés Reccius
Departamento de Medicina Intensiva, Clínica Las Condes, Santiago, Chile
1 shared publication Aníbal Zamorano
Department of Cardiology, Clínica Santa María, Santiago, Chile, clinicasantamaria.cl
1 shared publicationConstanza Gutiérrez
Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile
1 shared publication- Cristian Baeza
Department of Cardiac Surgery, University Hospitals Cleveland Medical Center , Cleveland, OH 44195
1 shared publication
Latest Publications
- 30 October 2026
- Published by Sociedad Chilena de Medicina Intensiva in Perspectives in Critical Care: Research and Education Journal
- Vol. 40 (1) , 1-121
Abstracts compliation
PresentaciónEs un honor darles la bienvenida al 44º Congreso Chileno de Medicina Intensiva2026, organizado por la Sociedad Chilena de Medicina Intensiva (SOCHIMI), que serealizará entre el 3 y el 6 de noviembre en el Hotel Marina Las Condes, en Santiago deChile.Nuestro Congreso constituye cada año un espacio privilegiado para el encuentro, laactualización y el intercambio de conocimientos entre los distintos profesionales queconforman la comunidad de la Medicina Intensiva. Dentro de este encuentro, la presentaciónde trabajos científicos ocupa un lugar especialmente relevante, pues representala capacidad de nuestros equipos para transformar las preguntas que surgende la práctica clínica en conocimiento que contribuya a mejorar el cuidado de nuestrospacientes.Esta revista reúne los trabajos científicos presentados durante el Congreso 2026 yrefleja la diversidad, el compromiso y el creciente desarrollo de la investigación enMedicina Intensiva en Chile. Cada uno de ellos es resultado del esfuerzo de profesionalesy equipos que, desde distintas instituciones y regiones de nuestro país, handedicado tiempo y trabajo a generar y compartir nuevo conocimiento.Como SOCHIMI, queremos reconocer especialmente a todos los autores que enviaronsus trabajos, así como al Comité Científico y Comité Organizador del Congreso,revisores y colaboradores que participaron en la evaluación y selección de los cientosde resúmenes recibidos. Su contribución permite fortalecer el carácter científicode nuestro Congreso y promover una cultura de investigación, colaboración y mejoracontinua.Esperamos que estas páginas no solo permitan conocer los trabajos presentados,sino que también estimulen nuevas preguntas, proyectos colaborativos y futurasinvestigaciones. El avance de nuestra especialidad requiere una comunidad capaz decompartir experiencias, analizar críticamente su práctica y generar evidencia.En nombre de la Sociedad Chilena de Medicina Intensiva, agradezco a todos quieneshan contribuido a hacer posible este Congreso y los invito a disfrutar de estos díasde encuentro, aprendizaje y colaboración.Bienvenidos al 44º Congreso Chileno de Medicina Intensiva SOCHIMI2026.
- 30 October 2026
- Published by Sociedad Chilena de Medicina Intensiva in Perspectives in Critical Care: Research and Education Journal
- Vol. 40 (1) , 1-121
Abstracts compliation
PresentaciónEs un honor darles la bienvenida al 44º Congreso Chileno de Medicina Intensiva2026, organizado por la Sociedad Chilena de Medicina Intensiva (SOCHIMI), que serealizará entre el 3 y el 6 de noviembre en el Hotel Marina Las Condes, en Santiago deChile.Nuestro Congreso constituye cada año un espacio privilegiado para el encuentro, laactualización y el intercambio de conocimientos entre los distintos profesionales queconforman la comunidad de la Medicina Intensiva. Dentro de este encuentro, la presentaciónde trabajos científicos ocupa un lugar especialmente relevante, pues representala capacidad de nuestros equipos para transformar las preguntas que surgende la práctica clínica en conocimiento que contribuya a mejorar el cuidado de nuestrospacientes.Esta revista reúne los trabajos científicos presentados durante el Congreso 2026 yrefleja la diversidad, el compromiso y el creciente desarrollo de la investigación enMedicina Intensiva en Chile. Cada uno de ellos es resultado del esfuerzo de profesionalesy equipos que, desde distintas instituciones y regiones de nuestro país, handedicado tiempo y trabajo a generar y compartir nuevo conocimiento.Como SOCHIMI, queremos reconocer especialmente a todos los autores que enviaronsus trabajos, así como al Comité Científico y Comité Organizador del Congreso,revisores y colaboradores que participaron en la evaluación y selección de los cientosde resúmenes recibidos. Su contribución permite fortalecer el carácter científicode nuestro Congreso y promover una cultura de investigación, colaboración y mejoracontinua.Esperamos que estas páginas no solo permitan conocer los trabajos presentados,sino que también estimulen nuevas preguntas, proyectos colaborativos y futurasinvestigaciones. El avance de nuestra especialidad requiere una comunidad capaz decompartir experiencias, analizar críticamente su práctica y generar evidencia.En nombre de la Sociedad Chilena de Medicina Intensiva, agradezco a todos quieneshan contribuido a hacer posible este Congreso y los invito a disfrutar de estos díasde encuentro, aprendizaje y colaboración.Bienvenidos al 44º Congreso Chileno de Medicina Intensiva SOCHIMI2026.
- 19 October 2026
- Published by Wiley in Oral Diseases
Association Between Oral Health Status at Admission and Length of Hospital Stay in the Intensive Care Unit: A Retrospective Cohort Study (2024–2025)
Background: Poor oral health is linked to prolonged hospitalization, but critical care data from Latin America remain virtually absent. This study characterized baseline oral health at intensive care unit (ICU) admission in a Chilean center and evaluated its association with ICU length of stay (LOS). Methods: A retrospective cohort study was conducted including first‐admission adults ( n = 105). Bedside clinical examinations at admission assessed the WHO Decayed, Missing, and Filled Teeth (DMFT) index, gingival inflammation, and salivary hypofunction. Adjusted associations with ICU LOS were evaluated using multivariable ordinary least squares (OLS) regression. Results: At admission, gingival inflammation and salivary hypofunction were each present in 90.5% of patients. The mean DMFT was 8.87 ± 9.40. In multivariable analysis, the DMFT index was not associated with ICU LOS ( β = −0.050, 95% CI [−0.187, 0.087], p = 0.477). Mechanical ventilation status emerged as the sole independent predictor of prolonged stay ( β = 3.30 days, 95% CI [0.75, 5.85], p = 0.013). Results were robust across five sensitivity analyses. Conclusions: Despite a remarkably high baseline burden of oral disease at ICU admission, chronic caries experience was not independently associated with ICU LOS, which was driven primarily by ventilatory support.
- 19 October 2026
- Published by Wiley in Oral Diseases
Association Between Oral Health Status at Admission and Length of Hospital Stay in the Intensive Care Unit: A Retrospective Cohort Study (2024–2025)
Background: Poor oral health is linked to prolonged hospitalization, but critical care data from Latin America remain virtually absent. This study characterized baseline oral health at intensive care unit (ICU) admission in a Chilean center and evaluated its association with ICU length of stay (LOS). Methods: A retrospective cohort study was conducted including first‐admission adults ( n = 105). Bedside clinical examinations at admission assessed the WHO Decayed, Missing, and Filled Teeth (DMFT) index, gingival inflammation, and salivary hypofunction. Adjusted associations with ICU LOS were evaluated using multivariable ordinary least squares (OLS) regression. Results: At admission, gingival inflammation and salivary hypofunction were each present in 90.5% of patients. The mean DMFT was 8.87 ± 9.40. In multivariable analysis, the DMFT index was not associated with ICU LOS ( β = −0.050, 95% CI [−0.187, 0.087], p = 0.477). Mechanical ventilation status emerged as the sole independent predictor of prolonged stay ( β = 3.30 days, 95% CI [0.75, 5.85], p = 0.013). Results were robust across five sensitivity analyses. Conclusions: Despite a remarkably high baseline burden of oral disease at ICU admission, chronic caries experience was not independently associated with ICU LOS, which was driven primarily by ventilatory support.
- Open Access
- 7 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1)
Left Ventricular Sarcoma Causing Dynamic Outflow Tract Obstruction and Cardiogenic Shock: A Case Report
Background: Primary cardiac sarcomas are rare and aggressive tumors that often present with nonspecific symptoms, typically diagnosed at advanced stages. Obstruction of the left ventricular outflow tract (LVOT) due to these tumors is an exceptionally rare and life‐threatening complication. Case Presentation: We describe the case of a previously healthy 33‐year‐old male who presented with progressive exertional dyspnea, orthopnea, and hemoptysis. Upon admission, he quickly developed hemodynamic instability and respiratory failure. Point‐of‐care transthoracic echocardiography revealed a large intracardiac mass causing dynamic LVOT obstruction. During intubation, the patient experienced cardiac arrest, necessitating advanced cardiopulmonary resuscitation. Urgent surgical intervention confirmed the presence of an infiltrative cardiac sarcoma with positive margins. The postoperative recovery was favorable, enabling extubation and withdrawal of vasoactive agents within 24 h. Discussion: Cardiac sarcomas often mimic other cardiovascular conditions, complicating early diagnosis. Imaging techniques such as echocardiography and cardiac MRI are essential for detection and characterization. The prognosis for patients with cardiac sarcomas remains poor due to the tumors′ infiltrative nature and high rates of recurrence; however, complete surgical resection is the cornerstone of treatment. Conclusion: This case underscores the necessity for clinical vigilance in patients presenting with unexplained cardiopulmonary symptoms. The early application of bedside echocardiography facilitated prompt diagnosis and timely surgical intervention, proving life‐saving in this instance of obstructive shock due to a primary cardiac sarcoma.
- 7 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1)
Open AccessLeft Ventricular Sarcoma Causing Dynamic Outflow Tract Obstruction and Cardiogenic Shock: A Case Report
Background: Primary cardiac sarcomas are rare and aggressive tumors that often present with nonspecific symptoms, typically diagnosed at advanced stages. Obstruction of the left ventricular outflow tract (LVOT) due to these tumors is an exceptionally rare and life‐threatening complication. Case Presentation: We describe the case of a previously healthy 33‐year‐old male who presented with progressive exertional dyspnea, orthopnea, and hemoptysis. Upon admission, he quickly developed hemodynamic instability and respiratory failure. Point‐of‐care transthoracic echocardiography revealed a large intracardiac mass causing dynamic LVOT obstruction. During intubation, the patient experienced cardiac arrest, necessitating advanced cardiopulmonary resuscitation. Urgent surgical intervention confirmed the presence of an infiltrative cardiac sarcoma with positive margins. The postoperative recovery was favorable, enabling extubation and withdrawal of vasoactive agents within 24 h. Discussion: Cardiac sarcomas often mimic other cardiovascular conditions, complicating early diagnosis. Imaging techniques such as echocardiography and cardiac MRI are essential for detection and characterization. The prognosis for patients with cardiac sarcomas remains poor due to the tumors′ infiltrative nature and high rates of recurrence; however, complete surgical resection is the cornerstone of treatment. Conclusion: This case underscores the necessity for clinical vigilance in patients presenting with unexplained cardiopulmonary symptoms. The early application of bedside echocardiography facilitated prompt diagnosis and timely surgical intervention, proving life‐saving in this instance of obstructive shock due to a primary cardiac sarcoma.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1) , 7875906
Acute Respiratory Failure due to Pulmonary Toxoplasmosis in an Immunocompetent Patient: A Case Report
Pulmonary toxoplasmosis is a rare but potentially life‐threatening manifestation of Toxoplasma gondii infection in immunocompetent individuals. Clinical presentation is often nonspecific and may mimic viral or atypical pneumonia, leading to delayed diagnosis. We report the case of a previously healthy 32‐year‐old man who presented with a mononucleosis‐like syndrome complicated by rapidly progressive hypoxemic respiratory failure requiring invasive mechanical ventilation. Initial evaluation revealed marked systemic inflammation, cytopenias, hyperferritinemia, and mixed‐pattern hepatitis. Chest computed tomography demonstrated bilateral consolidations, ground‐glass opacities, pleural effusions, and interstitial changes. Extensive microbiological and immunological investigations were initially unrevealing. Polymerase chain reaction (PCR) testing for T. gondii was positive in blood despite negative IgG serology and isolated IgM positivity, raising concern for potentially misleading serological findings. The diagnosis of pulmonary toxoplasmosis was subsequently confirmed by PCR detection of T. gondii DNA in bronchoalveolar lavage fluid. Targeted treatment with trimethoprim–sulfamethoxazole led to rapid clinical and biochemical improvement, allowing successful extubation after 6 days of mechanical ventilation and complete radiological resolution prior to discharge. This case highlights the diagnostic challenges of pulmonary toxoplasmosis in immunocompetent hosts and underscores the importance of molecular testing in critically ill patients with severe pneumonia and ambiguous serological findings.
- 1 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1) , 7875906
Open AccessAcute Respiratory Failure due to Pulmonary Toxoplasmosis in an Immunocompetent Patient: A Case Report
Pulmonary toxoplasmosis is a rare but potentially life‐threatening manifestation of Toxoplasma gondii infection in immunocompetent individuals. Clinical presentation is often nonspecific and may mimic viral or atypical pneumonia, leading to delayed diagnosis. We report the case of a previously healthy 32‐year‐old man who presented with a mononucleosis‐like syndrome complicated by rapidly progressive hypoxemic respiratory failure requiring invasive mechanical ventilation. Initial evaluation revealed marked systemic inflammation, cytopenias, hyperferritinemia, and mixed‐pattern hepatitis. Chest computed tomography demonstrated bilateral consolidations, ground‐glass opacities, pleural effusions, and interstitial changes. Extensive microbiological and immunological investigations were initially unrevealing. Polymerase chain reaction (PCR) testing for T. gondii was positive in blood despite negative IgG serology and isolated IgM positivity, raising concern for potentially misleading serological findings. The diagnosis of pulmonary toxoplasmosis was subsequently confirmed by PCR detection of T. gondii DNA in bronchoalveolar lavage fluid. Targeted treatment with trimethoprim–sulfamethoxazole led to rapid clinical and biochemical improvement, allowing successful extubation after 6 days of mechanical ventilation and complete radiological resolution prior to discharge. This case highlights the diagnostic challenges of pulmonary toxoplasmosis in immunocompetent hosts and underscores the importance of molecular testing in critically ill patients with severe pneumonia and ambiguous serological findings.
- 16 December 2020
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 49 (1) , e112-e113
Potentially Severe Traumatic Brain Injury: Let Us Consider Patient Context
- 16 December 2020
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 49 (1) , e112-e113
Potentially Severe Traumatic Brain Injury: Let Us Consider Patient Context
- Open Access
- 1 July 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 146 (7) , 938-941
Fibrosis pulmonar aguda asociada a intoxicación por Paraquat: caso clínico
Gran parte de sus intoxicaciones se deben a ingesta oral, sin embargo, existen reportes descritos en la literatura sobre intoxicación por administración intradérmica e intravenosa2. Usualmente los casos reportados de intoxicación en adultos son debido a intento suicida más que exposición accidental, siendo la prevalencia de intentos suicidas mayor en países de Asia3. Su ingestión genera toxicidad por liberación de radicales superóxido, afectando principalmente riñones, pulmones e hígado1,2. Sus principales efectos sistémicos son edema pulmonar, convulsiones, falla cardíaca, renal y hepática1 y no posee antídoto4.
- 1 July 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 146 (7) , 938-941
Open AccessFibrosis pulmonar aguda asociada a intoxicación por Paraquat: caso clínico
Gran parte de sus intoxicaciones se deben a ingesta oral, sin embargo, existen reportes descritos en la literatura sobre intoxicación por administración intradérmica e intravenosa2. Usualmente los casos reportados de intoxicación en adultos son debido a intento suicida más que exposición accidental, siendo la prevalencia de intentos suicidas mayor en países de Asia3. Su ingestión genera toxicidad por liberación de radicales superóxido, afectando principalmente riñones, pulmones e hígado1,2. Sus principales efectos sistémicos son edema pulmonar, convulsiones, falla cardíaca, renal y hepática1 y no posee antídoto4.
- Open Access
- 10 October 2017
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 20 (4) , 371-376
Leptospirosis-associated catastrophic respiratory failure supported by extracorporeal membrane oxygenation
A previously healthy, 39-year-old obese farmer, arrived hypotensive and tachycardic, with fever, myalgia, headache, abdominal pain, diarrhea, and progressive dyspnea. Ten days before symptoms onset, he was in direct contact with mice and working in a contaminated drain. Patient laboratory showed acute kidney injury and thrombocytopenia. Chest X-ray exhibited bilateral diffuse interstitial infiltrates. First-line empirical antibiotics were started and influenza discarded. Patient evolved with severe respiratory failure, associated with hemoptysis, and rapidly severe hemodynamic compromise. Despite neuromuscular blockade and prone positioning, respiratory failure increased. Accordingly, veno-venous ECMO was initiated, with bilateral femoral extraction and jugular return. After ECMO connection, there was no significant improvement in oxygenation, and low pre-membrane saturations and low arterial PaO2 of the membrane showed that we were out of the limits of the rated flow. Thus, a second membrane oxygenator was installed in parallel. Afterward, oxygenation improved, with subsequent perfusion enhancement. Regarding etiology, due to high suspicion index, Leptospira serology was performed, coming back positive and meropenem was maintained. The patient ultimately recovered and experience excellent outcome. The clinical relevance of the case is the scared evidence of leptospirosis-associated severe respiratory failure treated with ECMO. This experience emphasizes the importance of an optimal support, which requires enough membrane surface and flow for an obese, highly hyperdynamic patient, during this reversible disease. A high index of suspicion is needed for an adequate diagnosis of leptospirosis to implement the correct treatment, particularly in the association of respiratory failure, pulmonary hemorrhage, and an epidemiological-related context.
- 10 October 2017
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 20 (4) , 371-376
Open AccessLeptospirosis-associated catastrophic respiratory failure supported by extracorporeal membrane oxygenation
A previously healthy, 39-year-old obese farmer, arrived hypotensive and tachycardic, with fever, myalgia, headache, abdominal pain, diarrhea, and progressive dyspnea. Ten days before symptoms onset, he was in direct contact with mice and working in a contaminated drain. Patient laboratory showed acute kidney injury and thrombocytopenia. Chest X-ray exhibited bilateral diffuse interstitial infiltrates. First-line empirical antibiotics were started and influenza discarded. Patient evolved with severe respiratory failure, associated with hemoptysis, and rapidly severe hemodynamic compromise. Despite neuromuscular blockade and prone positioning, respiratory failure increased. Accordingly, veno-venous ECMO was initiated, with bilateral femoral extraction and jugular return. After ECMO connection, there was no significant improvement in oxygenation, and low pre-membrane saturations and low arterial PaO2 of the membrane showed that we were out of the limits of the rated flow. Thus, a second membrane oxygenator was installed in parallel. Afterward, oxygenation improved, with subsequent perfusion enhancement. Regarding etiology, due to high suspicion index, Leptospira serology was performed, coming back positive and meropenem was maintained. The patient ultimately recovered and experience excellent outcome. The clinical relevance of the case is the scared evidence of leptospirosis-associated severe respiratory failure treated with ECMO. This experience emphasizes the importance of an optimal support, which requires enough membrane surface and flow for an obese, highly hyperdynamic patient, during this reversible disease. A high index of suspicion is needed for an adequate diagnosis of leptospirosis to implement the correct treatment, particularly in the association of respiratory failure, pulmonary hemorrhage, and an epidemiological-related context.
- Open Access
- 1 August 2017
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 145 (8) , 1072-1075
Acidosis láctica asociada a metformina. Caso clínico
Metformin-associated lactic acidosis is a severe and infrequent adverse event. Early diagnosis is essential to start an early treatment, which often has favorable results. We report a 56 years old non-insulin-requiring type 2 diabetic female who developed a severe metabolic acidosis associated with metformin in relation to an acute renal failure secondary to infectious diarrhea. Early treatment with bicarbonate and continuous hemofiltration allowed a quick improvement of the patient. Metformin-associated lactic acidosis has an elevated mortality (50-80%) and has a specific and effective treatment. Therefore, the condition must be born in mind.
- 1 August 2017
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 145 (8) , 1072-1075
Open AccessAcidosis láctica asociada a metformina. Caso clínico
Metformin-associated lactic acidosis is a severe and infrequent adverse event. Early diagnosis is essential to start an early treatment, which often has favorable results. We report a 56 years old non-insulin-requiring type 2 diabetic female who developed a severe metabolic acidosis associated with metformin in relation to an acute renal failure secondary to infectious diarrhea. Early treatment with bicarbonate and continuous hemofiltration allowed a quick improvement of the patient. Metformin-associated lactic acidosis has an elevated mortality (50-80%) and has a specific and effective treatment. Therefore, the condition must be born in mind.